Frédéric Tangy, PhD, Dr.Sc., is the Director of Research at CNRS and at Institut Pasteur in Paris, France, where they lead research efforts in viral genomics and vaccination. They co-founded Oncovita, a biotech company specializing in oncovirotherapy, and have authored over 200 articles while holding 28 patents during their 25-year research career. Tangy's work primarily focuses on virus-host interactions and the development of novel viral therapies, particularly utilizing the Measles virus for innovative vaccine and cancer treatment applications. They have successfully guided vaccine candidates through various clinical trial phases, further establishing their expertise in virology and immunology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices